Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal).

Frédéric Dumont,Michèle Boisdron-Celle,Sandrine Hiret,Hélène Senellart,Judith Raimbourg,Loïc Campion,F Pein,Naoual Bakrin,Jean-Luc Raoul,Olivier Glehen,Emilie Thibaudeau

Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal).

2019

Frédéric Dumont
Michèle Boisdron-Celle
Sandrine Hiret
Hélène Senellart
Judith Raimbourg
Loïc Campion
F Pein
Naoual Bakrin
Jean-Luc Raoul
Olivier Glehen
Emilie Thibaudeau

e15027Background: The pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new route of intraperironeal drug administration that enhances the absorption of oxaliplatin. The objectives were...

Keywords:

digestive cancer
Internal medicine
intraperitoneal chemotherapy
dose escalation
Stomach
Medicine
phase i ii
Gastroenterology
Oxaliplatin
Chemotherapy
drug administration

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations